Theresa Mills-floyd, MD in Chapin, SC - Internal Medicine

Theresa Mills-floyd, MD is a Internal Medicine physician based in Chapin, South Carolina. Theresa Mills-floyd is licensed to practice in South Carolina (license number 22602) and her current practice location is 47 Love Valley Ct, Chapin, South Carolina. She can be reached at her office (for appointments etc.) via phone at (803) 781-7057.

NPI number for Theresa Mills-floyd is 1700989654 and her current mailing address is 47 Love Valley Ct, Chapin, South Carolina. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1700989654.

Contact Information

	Theresa Mills-floyd, MD
	47 Love Valley Ct, Chapin, SC 29036-8591
	(803) 781-7057
	Not Available

Physician's Profile

Full Name	Theresa Mills-floyd
Gender	Female
Speciality	Internal Medicine
Location	47 Love Valley Ct, Chapin, South Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1700989654
Provider Enumeration Date: 09/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Theresa Mills-floyd such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1700989654	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207R00000X	Internal Medicine	22602 (South Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Theresa Mills-floyd is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Theresa Mills-floyd, MD 47 Love Valley Ct, Chapin, SC 29036-8591 Ph: (803) 781-7057	Theresa Mills-floyd, MD 47 Love Valley Ct, Chapin, SC 29036-8591 Ph: (803) 781-7057

News Archive

Stem Cell Therapy International-Histostem merger on schedule

Stem Cell Therapy International, Inc. announced that its pre-closing conditions for its merger with Histostem Co. Ltd. ("Histostem") are proceeding on schedule with an expected close of the merger in January 2010.

WHO develops innovative system to track attacks on health workers

In the early hours of 3 October, rockets slammed into a Médecins Sans Frontières (MSF) hospital in Kunduz, Afghanistan, killing at least 14 health workers and injuring 37. An MSF clinic in the southern Yemen city of Taiz was bombed on 2 December, injuring 9 people, including 2 MSF staff.

New blood test can help determine the state of a person's internal clock

With a new blood test, researchers at the Charité - Universitätsmedizin Berlin can determine the state of the internal clock of a person. Once the internal rhythm of patient is known, drugs could be administered at particular times of day making them more effective and with fewer side effects than standard therapy.

HHS Secretary reinforces commitment to move forward with implementation of CLASS Act

In a briefing today at the Kaiser Family Foundation on "Opportunities for Long-Term Services and Supports in the Health Reform Law," U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius reinforced the Administration's commitment to moving forward with the implementation of Community Living Assistance Services and Supports (CLASS) Act.

Multiple studies examine ideal biomarkers for Huntington's disease

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.

Theresa Mills-floyd, MD - Internal Medicine in Chapin, SC